AIG
SLNO

American International Group’s Soleno Therapeutics SLNO Stock Holding History

American International Group’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,314
Closed -$44 – 3259
2021
Q1 		$44 Buy
2,314
+6
+0.3% +$193 ﹤0.01% 3014
2020
Q4 		$67 Sell
2,308
-66
-3% -$1.91K ﹤0.01% 2855
2020
Q3 		$89K Buy
2,374
+1,010
+74% +$29.5K ﹤0.01% 2591
2020
Q2 		$45K Buy
+1,364
New +$59.1K ﹤0.01% 2915

Other funds holding SLNO

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

American International Group's SLNO Position: Q2 2021 in Review

American International Group sold out of Soleno Therapeutics (SLNO) in Q2 2021, closing a stake of 2,314 shares — an estimated $44 sold.

American International Group first reported a position in SLNO in Q2 2020 and held it in 4 quarters. The position peaked at $89K in Q3 2020. 47 funds tracked by Wall St. Rank hold SLNO as of Q2 2021.

  • American International Group reported no remaining Soleno Therapeutics position as of Q2 2021 after selling out during the quarter.
  • American International Group sold 2,314 Soleno Therapeutics shares in Q2 2021, an estimated $44.
  • American International Group first reported a position in Soleno Therapeutics in Q2 2020 and held it in 4 quarters.
  • American International Group's Soleno Therapeutics position peaked at $89K in Q3 2020.
  • 47 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.